The University of Chicago Header Logo

Connection

Walter M. Stadler to Calgranulin B

This is a "connection" page, showing publications Walter M. Stadler has written about Calgranulin B.
Connection Strength

0.025
  1. Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer. J Clin Oncol. 2011 Oct 20; 29(30):4022-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.